Societies

Zev Wainberg discussing the 3-year OS data from the TOPAZ-1 trial

Photo from Zev Wainberg from X

Jun 29, 2024, 10:55

Zev Wainberg discussing the 3-year OS data from the TOPAZ-1 trial

Lorenza Rimassa, Associate Professor of Medical Oncology at HUNIMED, shared on X:

“Zev Wainberg discussing the 3-year OS data from the TOPAZ-1 trial in biliary tract cancer and the OPTIMIZE-1 in pancreatic cancer. Which are the open questions and future perspectives?”

Zev Wainberg

Source: Lorenza Rimassa/X

Biliary tract cancer cancer ESMOGI24 HUNIMED Lorenza Rimassa OncoDaily Oncology OPTIMIZE-1 Pancreatic Cancer TOPAZ-1 Zev Wainberg

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Blog Posts

Aug 18, 2025, 20:36

Gashaw Arega: The Beginning of Childhood Cancer Care in Ethiopia

Opinion

Aug 18, 2025, 20:22

Soumen Das: From LMIC to LRS - Rethinking Global Health

Health Policy

Aug 18, 2025, 20:12

Niranjala Siriwardena: Building Australia’s First Workplace Cancer Survivorship Policy

Voices

Aug 18, 2025, 20:02

Confronting Stigma at the Crossroads of Hepatitis and Cancer - European Cancer Organisation

Positive

Aug 18, 2025, 19:53

Erin and Chloe Raise £800 for Lung Cancer Research - Oncogene Cancer Research

Blog Posts

Aug 18, 2025, 19:28

Liz O’Riordan: Everything You Need to Know about Breast Cancer Recurrence

Blog Posts

Aug 18, 2025, 19:17

Matteo Bauckneht: Pitfalls in PSMA-Based RLT - A Case-Based Review at EANM25

Insight

Aug 18, 2025, 18:55

NCODA Brings the BREAKWATER Trial into Practice

Blog Posts

Aug 18, 2025, 18:20

Amol Akhade: Key Late-Breaking and Practice-Changing Trials to Watch at WCLC 2025

Insight

Aug 18, 2025, 18:09

Hung Trinh Highlights Pasritamig, a First-in-Class T-Cell Engager for Prostate Cancer

Voices

Aug 18, 2025, 17:43

Building a Healthier Future for Women Also Means Building a Healthier Future for the Next Generation - Elekta Foundation

Voices

Aug 18, 2025, 17:35

Mandar Muzumdar: The Evolution of Single-Cell 3D Genomes in KRAS-Driven Cancers